Published in Gene Therapy Weekly, February 24th, 1997
Animal models with artificially induced liver tumors of colorectal origin treated locally with either retrovirus or adenovirus vector-mediated HSV-tk/GCV suicide gene therapy have been studied previously. Although extensive testing of retroviral vectors has not revealed any major signs of toxicity (D.W. Moorman, J. Surg. Oncol., 1994;57:152-6), no toxicity studies using adenoviral mediated HSV-tk/GCV gene therapy have been reported to date.
Karsten Brand and colleagues...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.